Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease

Haematologica

Volumn 94, Issue 11, 2009, Pages 1513-1519

  Van Beers, Eduard J ^a,b   Schaap, Marianne C L ^a   Berckmans, René J ^a   Nieuwland, Rienk ^a   Sturk, Augueste ^a   Van Doormaal, Frederiek F ^a   Meijers, Joost C M ^a   Biemond, Bart J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Coagulation activation; Hemolysis; Microparticles; Sickle cell disease

Indexed keywords

BLOOD CLOTTING FACTOR 11; CD61 ANTIGEN; GLYCOPHORIN A; GLYCOPROTEIN IIIA; THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PLATELET MICROPARTICLE; SICKLE CELL ANEMIA;

ADULT; ANEMIA, SICKLE CELL; BLOOD COAGULATION; CELL-DERIVED MICROPARTICLES; ERYTHROCYTES; FACTOR XI; FEMALE; HUMANS; MALE;

EID: 70449382364     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.008938     Document Type: Article

References (26)

1. Stuart PM, Nagel PR. Sickle-cell disease. Lancet 2004;364:1343-1360
2. Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 2003;115:721-728 (Pubitemid 38032666)
3. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002;99:36-43.
4. Stief TW. Phospholipids trigger recalcified thrombin generation. Hemostasis Laboratory 2008;1:167-178
5. Setty BNY, Rao AK, Stuart MJ. Thrombophilia in sickle cell disease: the red cell connection. Blood 2001;98:3228-3233
6. Westerman MP, Cole ER, Wu K. The effect of spicules obtained from sickle red cells on clotting activity. Br J Haematol 1984;56:557-562 (Pubitemid 14128132)
7. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34:392-401.
8. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003;102:2678-2683 (Pubitemid 37193612)
9. Nieuwland R, Berckmans RJ, Rotteveel- Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997;96:3534-3541 (Pubitemid 27513430)
10. Hugel B, Socie G, Vu T, Toti F, Gluckman E, Freyssinet JM, et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999;93:3451-3456 (Pubitemid 29220912)
11. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000;95:930-935 (Pubitemid 30063043)
12. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001;85:810-820 (Pubitemid 32421813)
13. Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn FP, Kraan MC, et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 2002; 46: 2857-2866 (Pubitemid 35315876)
14. Lok CA, Nieuwland R, Sturk A, Hau CM, Boer K, Vanbavel E, et al. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets 2007;18:68-72. (Pubitemid 46269614)
15. Pattanapanyasat K, Gonwong S, Chaichompoo P, Noulsri E, Lerdwana S, Sukapirom K, et al. Activated platelet-derived microparticles in thalassaemia. Br J Haematol 2007;136:462-471
16. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16
17. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639-646 (Pubitemid 32293699)
18. Chitambar CR, Loebel AL, Noble NA. Shedding of transferrin receptor from rat reticulocytes during maturation in vitro: soluble transferrin receptor is derived from receptor shed in vesicles. Blood 1991;78: 2444-2450
19. Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, Cheung A, et al. Platelet activation in patients with sickle cell disease. Br J Haematol 1998;100:741-749 (Pubitemid 28126109)
20. Allan D, Limbrick AR, Thomas P, Westerman MP. Release of spectrinfree spicules on reoxygenation of sickled erythrocytes. Nature 1982; 295:612-613
21. Heller PG, Grinberg AR, Lencioni M, Molina MM, Roncoroni AJ. Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. Chest 1992;102:642-643
22. Horne MK III, Cullinane AM, Merryman PK, Hoddeson EK. The effect of red blood cells on thrombin generation. Br J Haematol 2006; 133:403-408
23. Fontana V, Jy W, Ahn ER, Dudkiewicz P, Horstman LL, Duncan R et al. Increased procoagulant cellderived microparticles (C-MP) in splenectomized patients with ITP. Thromb Res 2008;122: 599-603.
24. Setty BN, Kulkarni S, Stuart MJ. Role of erythrocyte phosphatidylserine in sickle red cellendothelial adhesion. Blood 2002; 99:1564-1571 (Pubitemid 34533027)
25. Malleier JM, Oskolkova O, Bochkov V, Jerabek I, Sokolikova B, Perkmann T, et al. Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids. Blood 2007; 109:4769-4776 (Pubitemid 46827770)
26. von dem Borne PA, Meijers JC, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995;86:3035-3042